Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Current price $94.55
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Aug 17, 26 | Teles De Mendonca Ana Paula | officer: President, Scent | S-Sale | 5,718 @ $83.19 | $475.7K |
Daily · Wilder smoothing
| Oct 22, 26 |
| Oppenheimer |
| maintain |
| Outperform |
| Outperform |
| Oct 16, 26 | Barclays | maintain | Overweight | Overweight |
| Oct 7, 26 | Argus Research | maintain | Buy | Buy |
| Oct 7, 26 | Citigroup | maintain | Buy | Buy |
| Aug 7, 26 | Barclays | maintain | Overweight | Overweight |
| Aug 6, 26 | Benchmark | maintain | Buy | Buy |
| Aug 6, 26 | UBS | maintain | Neutral | Neutral |
| Jul 1, 26 | Morgan Stanley | maintain | Overweight | Overweight |
| Jun 30, 26 | Argus Research | maintain | Buy | Buy |
| Aug 7, 26 |
| Birenkrant Marc |
| officer: Controller & CAO |
| S-Sale |
| 1,000 @ $85.00 |
| $85.00K |
| Aug 6, 26 | Deveau Michael | officer: EVP, CFO | S-Sale | 8,825 @ $85.55 | $755.0K |
| Jun 1, 26 | Fribourg Paul J | director | P-Purchase | 260,000 @ $74.28 | $19.31M |
| Jun 1, 26 | Fribourg Paul J | director | P-Purchase | 13,500 @ $74.49 | $1.01M |
| May 4, 26 | Teles De Mendonca Ana Paula | officer: President, Scent | M-Exempt | 708 | — |
| May 4, 26 | Teles De Mendonca Ana Paula | officer: President, Scent | M-Exempt | 708 | — |
| May 4, 26 | Teles De Mendonca Ana Paula | officer: President, Scent | F-InKind | 362 @ $70.09 | $25.37K |
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 80.46 | Oscillator | Sell |
| Stochastic %K (14, 3, 3) | 96.07 | Oscillator | Sell |
| Williams %R (14) | -0.95 | Oscillator | Sell |
| MACD (12, 26, 9) | 2.29 (Hist 0.82) | Oscillator | Strong Buy |
| Average Directional Index (14) | 27.33 (+DI 36.0 / -DI 11.4) | Trend | Strong Buy |
| EMA 20 | 88.66 | MA | Strong Buy |
| SMA 20 | 87.28 | MA | Strong Buy |
| EMA 50 | 85.89 | MA | Strong Buy |
| SMA 50 | 85.89 | MA | Strong Buy |
| SMA 200 | 77.97 | MA | Strong Buy |
Stock news · updated daily
NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) today announced that it will release its third quarter 2026 earnings results following the market close on Tuesday, November 3, 2026. The management team will host a live webcast on Wednesday, November 4, 2026, at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the company's website at ir.iff.com. For those unable to listen to the live webcast, a recor.
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF)—a global leader in flavors, fragrances and health and biosciences, published its latest resource, Dear Dairy: The Life Stages Guide. This strategic guide reveals how manufacturers can unlock new opportunities by aligning dairy innovation with consumers' evolving needs throughout life. “Dairy is one of the few categories that evolves alongside consumers throughout their lives,” said Rogerio de Almeida Prado, vice president of Global Dairy & BBC (Bak.
[url="]IFF[/url] (NYSE: IFF), a global leader in flavors, fragrances and health and biosciences, today introduced AQUASCENTâ¢, a new vegan, water-based carrier
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF), a global leader in flavors, fragrances and health and biosciences, today introduced AQUASCENT™, a new vegan, water-based carrier for fine fragrance. Crafted from a proprietary formula made with biodegradable materials, AQUASCENT™ delivers enhanced olfactive performance and visual clarity for consumers while supporting a more sustainable approach to shipping the product. “AQUASCENT™ reflects our continued investment in new scent technologies and format.
Nykredit A S purchased a new stake in International Flavors and Fragrances Inc. (NYSE: IFF) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 2,025,881 shares of the specialty chemicals company's stock, valued at approximately $160,490,000. Nykredit A S
Bank of America Corp DE purchased a new position in shares of International Flavors and Fragrances Inc. (NYSE: IFF) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,663,214 shares of the specialty chemicals company's stock, valued
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) — a global leader in flavors, fragrances and health and biosciences — today announced the launch of Omni-Bos™ PHY, a novel phytase enzyme designed specifically for dairy cattle. The technology helps producers improve nutrient utilization and feed efficiency by unlocking nutrients already present in feed, enabling cows to derive greater value from existing feed ingredients. Omni-Bos™ PHY will initially launch in the Middle East, Africa and Asia-Pacific.
Corient Private Wealth LP trimmed its holdings in shares of International Flavors and Fragrances Inc. (NYSE: IFF) by 51.3% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 127,604 shares of the specialty chemicals company's stock after selling 134,384 shares during the period. Corient
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | 1.07 | 0.82 | Miss -23.4% | $1.95B |
| May 5, 2026 | 1.07 | 1.25 | Beat 16.8% | $2.74B |
| Feb 11, 2026 | 0.83 | 0.80 | Miss -3.4% | $2.59B |
| Nov 4, 2025 | 1.02 | 1.05 | Beat 2.9% | $2.69B |
| Aug 5, 2025 | 1.12 | 1.15 | Beat 2.7% | $2.76B |
| May 6, 2025 | 1.13 | 1.20 | Beat 6.2% | $2.84B |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 25-NSE | Sep 25, 2026 | 2026-09-25 11:05:09 | View |
| 4 | Aug 19, 2026 | 2026-08-19 09:09:44 | View |
| 4 | Aug 10, 2026 | 2026-08-10 17:03:34 | View |
| 4 | Aug 7, 2026 | 2026-08-07 17:21:39 | View |
| 8-K | Aug 4, 2026 | 2026-08-04 16:40:10 | View |
| 10-Q | Aug 4, 2026 | 2026-08-04 16:34:42 | View |
| 8-K | Aug 4, 2026 | 2026-08-04 16:24:34 | View |
| 11-K | Jun 29, 2026 | 2026-06-29 16:47:07 | View |
| 8-K | Jun 23, 2026 | 2026-06-23 16:39:50 | View |
| 4 | Jun 2, 2026 | 2026-06-02 17:22:26 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | IFF | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 86.7x | 31.4x · sector 16.6x | Elevated |
| Forward P/E (FY26E) | 28.0x | EPS est. 3.37 | Discount |
| Price / Book | 1.7x | 1.5x | Elevated |
| Price / Sales | 2.4x | 2.1x | In line |
| EV / EBITDA | 20.1x | -60.1x | Discount |
| Return on equity | 2.1% | — | Weak |
| Gross margin | 37.5% | 33.9% | In line |
| Debt / Equity | 0.45 | 0.63 | Conservative |
| Piotroski / Altman Z | 7/9 | Z 1.75 | Distress |
Discounted cash flow model
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure